These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25625510)

  • 21. Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China.
    Ye Z; Abduhilil R; Huang J; Sun L
    Appl Health Econ Health Policy; 2022 Nov; 20(6):893-904. PubMed ID: 35934772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
    Nimdet K; Ngorsuraches S
    BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disentangling WTP per QALY data: different analytical approaches, different answers.
    Gyrd-Hansen D; Kjaer T
    Health Econ; 2012 Mar; 21(3):222-37. PubMed ID: 21254305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Willingness-to-Pay for One Quality-Adjusted Life-Year: A Population-Based Study from Iran.
    Lankarani KB; Ghahramani S; Moradi N; Shahraki HR; Lotfi F; Honarvar B
    Appl Health Econ Health Policy; 2018 Dec; 16(6):837-846. PubMed ID: 30123949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia.
    Lim YW; Shafie AA; Chua GN; Ahmad Hassali MA
    Value Health; 2017 Sep; 20(8):1131-1138. PubMed ID: 28964445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of a QALY towards the end of life and its determinants: Experimental evidence.
    Fischer B; Telser H; Zweifel P; von Wyl V; Beck K; Weber A
    Soc Sci Med; 2023 Jun; 326():115909. PubMed ID: 37121067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of dementia care towards the end of life-A contingent valuation study.
    Bhattarai N; Mason H; Kernohan A; Poole M; Bamford C; Robinson L; Vale L
    Int J Geriatr Psychiatry; 2020 May; 35(5):489-497. PubMed ID: 31912572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
    King JT; Tsevat J; Lave JR; Roberts MS
    Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment.
    Yin Y; Peng Q; Ma L; Dong Y; Sun Y; Xu S; Ding N; Liu X; Zhao M; Tang Y; Mei Z; Shao H; Yan D; Tang W
    Qual Life Res; 2024 Mar; 33(3):753-765. PubMed ID: 38079024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of a QALY and VSI estimated with the chained approach.
    Olofsson S; Gerdtham UG; Hultkrantz L; Persson U
    Eur J Health Econ; 2019 Sep; 20(7):1063-1077. PubMed ID: 31172400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec.
    Kouakou CRC; He J; Poder TG
    Eur J Health Econ; 2024 Jul; 25(5):787-811. PubMed ID: 37656261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of Patients' Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan.
    Chen YT; Ying YH; Chang K; Hsieh YH
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26938547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Willingness to pay for quality and length of life gains in end of life patients of different ages.
    Reckers-Droog V; van Exel J; Brouwer W
    Soc Sci Med; 2021 Jun; 279():113987. PubMed ID: 33975052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a kink in consumers' threshold value for cost-effectiveness in health care?
    O'Brien BJ; Gertsen K; Willan AR; Faulkner LA
    Health Econ; 2002 Mar; 11(2):175-80. PubMed ID: 11921315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
    Thavorncharoensap M; Teerawattananon Y; Natanant S; Kulpeng W; Yothasamut J; Werayingyong P
    Clinicoecon Outcomes Res; 2013; 5():29-36. PubMed ID: 23345984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Willingness to pay for one quality-adjusted life year in Iran.
    Moradi N; Rashidian A; Nosratnejad S; Olyaeemanesh A; Zanganeh M; Zarei L
    Cost Eff Resour Alloc; 2019; 17():4. PubMed ID: 30867654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia.
    Shafie AA; Lim YW; Chua GN; Hassali MA
    Clinicoecon Outcomes Res; 2014; 6():473-81. PubMed ID: 25364267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care.
    Clarke PM
    Health Econ; 2002 Mar; 11(2):117-27. PubMed ID: 11921310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation.
    Neumann PJ; Johannesson M
    Med Care; 1994 Jul; 32(7):686-99. PubMed ID: 8028404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?
    Shiroiwa T; Sung YK; Fukuda T; Lang HC; Bae SC; Tsutani K
    Health Econ; 2010 Apr; 19(4):422-37. PubMed ID: 19382128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.